Immunoglobulin A A next generation of therapeutic antibodies?

被引:74
作者
Bakema, Jantine E. [1 ]
van Egmond, Marjolein [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands
关键词
IgA; SIgA; dIgA; CD89; FcaRI; therapy; pro-inflammatory; mucosal defence; tumor; ITAM;
D O I
10.4161/mabs.3.4.16092
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although immunoglobulin (Ig) A is commonly recognized as the most prevalent antibody subclass at mucosal sites with an important role in mucosal defense, its potential as a therapeutic monoclonal antibody is less well known. However, IgA has multifaceted anti-, non- and pro-inflammatory functions that can be exploited for different immunotherapeutical strategies, which will be the focus of this review.
引用
收藏
页码:352 / 361
页数:10
相关论文
共 143 条
[1]   Inside-out regulation of FcαRI (CD89) depends on PP2A [J].
Bakema, Jantine E. ;
Bakker, Annie ;
de Haij, Simone ;
Honing, Henk ;
Bracke, Madelon ;
Koenderman, Leo ;
Vidarsson, Gestur ;
van de Winkel, Jan G. J. ;
Leusen, Jeanette H. W. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (06) :4080-4088
[2]   Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor γ-chain interaction [J].
Bakema, Jantine E. ;
de Haij, Simone ;
den Hartog-Jager, Constance F. ;
Bakker, Johanna ;
Vidarsson, Gestur ;
van Egmond, Marjolein ;
de Winkel, Jan G. J. van ;
Leusen, Jeanette H. W. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (06) :3603-3610
[3]   c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcαRI and FcR γ-chain [J].
Bakema, Jantine E. ;
Hiemstra, Ida H. ;
Bakker, Johanna ;
de Haij, Simone ;
Kok, Yvonne ;
Adema, Gosse ;
van Egmond, Marjolein ;
Coffer, Paul J. ;
van de Winkel, Jan G. J. ;
Leusen, Jeanette H. W. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (07) :2035-2040
[4]  
Bakema JE, 2011, J IMMUNOL IN PRESS
[5]   GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ENHANCES NEUTROPHIL FUNCTION IN ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS [J].
BALDWIN, GC ;
GASSON, JC ;
QUAN, SG ;
FLEISCHMANN, J ;
WEISBART, R ;
OETTE, D ;
MITSUYASU, RT ;
GOLDE, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2763-2766
[6]   A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis [J].
Balu, Sucharitha ;
Reljic, Rajko ;
Lewis, Melanie J. ;
Pleass, Richard J. ;
McIntosh, Richard ;
van Kooten, Cees ;
van Egmond, Marjolein ;
Challacombe, Stephen ;
Woof, Jenny M. ;
Ivanyi, Juraj .
JOURNAL OF IMMUNOLOGY, 2011, 186 (05) :3113-3119
[7]   Serum-free production and purification of chimeric IgA antibodies [J].
Beyer, T. ;
Lohse, S. ;
Berger, S. ;
Peipp, M. ;
Valerius, T. ;
Dechant, M. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 346 (1-2) :26-37
[8]   UREASE-SPECIFIC MONOCLONAL-ANTIBODIES PREVENT HELICOBACTER-FELIS INFECTION IN MICE [J].
BLANCHARD, TG ;
CZINN, SJ ;
MAURER, R ;
THOMAS, WD ;
SOMAN, G ;
NEDRUD, JG .
INFECTION AND IMMUNITY, 1995, 63 (04) :1394-1399
[9]   Inhibitory ITAMs as novel regulators of immunity [J].
Blank, Ulrich ;
Launay, Pierre ;
Benhamou, Marc ;
Monteiro, Renato C. .
IMMUNOLOGICAL REVIEWS, 2009, 232 :59-71
[10]   The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: A study by X-ray and neutron solution scattering and homology modelling [J].
Boehm, MK ;
Woof, JM ;
Kerr, MA ;
Perkins, SJ .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (05) :1421-1447